Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
198 hedge funds and large institutions have $1.22B invested in Immunogen Inc in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 74 increasing their positions, 55 reducing their positions, and 32 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 55
11% more capital invested
Capital invested by funds: $1.1B → $1.22B (+$119M)
1% more call options, than puts
Call options by funds: $8.07M | Put options by funds: $8.01M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 204 → 198 (-6)
13% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$41.4M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$27.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.3M |
| 4 |
BlackRock
New York
|
+$21.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$17.6M |
| 2 |
Millennium Management
New York
|
-$14.5M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$9.86M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.69M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$7.26M |
IMGN Hedge Fund Activity: Q2 2018 in Review
198 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2018, worth a combined $1.22B — up 11% from $1.1B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of IMGN and 28 opened new positions — a net loss of 4 holders — while 55 trimmed existing stakes and 74 added.
The largest buyer was Capital Research Global Investors, adding an estimated $41.4M. The largest seller was PointState Capital, exiting entirely with an estimated $17.6M sold.
- 198 institutional investors held Immunogen Inc (IMGN) as of Q2 2018, down from 204 in Q1 2018.
- Funds reported $1.22B of Immunogen Inc stock for Q2 2018, up 11% quarter-over-quarter.
- 28 funds opened new Immunogen Inc positions in Q2 2018 and 32 closed out, a net change of -4 holders.
- The largest Immunogen Inc buyer in Q2 2018 was Capital Research Global Investors, an estimated $41.4M added.
- The largest Immunogen Inc seller in Q2 2018 was PointState Capital, an estimated $17.6M sold.
Based on aggregated 13F filings for Q2 2018.